Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 4/20 | 0.34 |
| ▸ | HRH2 | P25021 | 7/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 4/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17452712 | 0.88 | ROCK2 (0.36) | HTR2AHRH2ALDH1A1KDM4ELMNA | |
| SCHEMBL20229534 | 0.86 | HRH3 (0.38) | HTR2AHTR2CHRH2ROCK2LTA4H | |
| SCHEMBL20229638 | 0.86 | THRB (0.35) | HTR2AHTR2BHRH2ALDH1A1KDM4E | |
| SCHEMBL17454519 | 0.85 | MAOB (0.39) | HTR2AHRH2ALDH1A1KDM4EROCK2 | |
| SCHEMBL19902336 | 0.84 | GAA (0.38) | HTR2AHRH2ALDH1A1KDM4ELMNA | |
| SCHEMBL17452714 | 0.75 | KDM4E (0.39) | HTR2AHRH2ALDH1A1KDM4ELMNA | |
| SCHEMBL17452724 | 0.75 | KDM4E (0.39) | HTR2AHRH2ALDH1A1KDM4ELMNA | |
| SCHEMBL20229606 | 0.73 | KDM4E (0.39) | HRH2ALDH1A1KDM4ELMNAROCK2 | |
| SCHEMBL17452710 | 0.73 | HRH3 (0.41) | HTR2AHTR2CALDH1A1KDM4EROCK2 | |
| SCHEMBL17452713 | 0.73 | KDM4E (0.39) | ALDH1A1KDM4EROCK2MEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180155296-A1 | SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK | BRISTOL MYERS SQUIBB CO (US) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180155296-A1 | SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK | ROCK1, MYLK, ROCK2 | HTR2A 3174/4885HTR2C 2653/4885HTR2B 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.